News Detail
New Delhi, 6 Feb 2025: India’s key drug policy body, the Drugs Technical Advisory Board (DTAB), ceased to exist in October after its three-year term ended, leading to a halt in all drug-related policy activities in the country, according to a report by Mint. The lapse......
View Details
Source : Moneycontrol
India drug advisory body
Drugs Technical Advisory Board
DTAB reconstitution
Indian health ministry
drug policy decisions
antimicrobial resistance
Drugs and Cosmetics Act
Drugs Controller General of India
DCC meeting
pharmaceutical policy
GMP compliance
nutraceutical products
Indian pharmaceutical regulations
Related News
- Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel (25-03-2025)
- Supplement firm Bioventra warns of online fakes (25-03-2025)
- FDA drug approvals drops, but smaller pharma leads innovation: GlobalData (25-03-2025)
- No staff involved in promoting fake drugs, vaccination: Odisha Health Minister (25-03-2025)
- Centre to introduce standardised hospital billing format to ensure transparency (24-03-2025)
- CDSCO asks MSME pharma firms to apply online for Schedule M extension (24-03-2025)
- Father and son arrested for unlicensed medicine sales, concealed drugs in cowshed (24-03-2025)
- AI-driven device by PGI set to transform neuropathic pain diagnosis (24-03-2025)
- Chhattisgarh EOW Arrests Five Officers in ₹660 Cr Procurement Scam (24-03-2025)
- Man caught at Silchar Medical College for allegedly overpricing medicines (24-03-2025)